HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Massimo D'Apuzzo Selected Research
Massimo D'Apuzzo Research Topics
Disease
19
Neoplasms (Cancer)
01/2022 - 12/2009
11
Glioma (Gliomas)
01/2022 - 12/2009
6
Glioblastoma (Glioblastoma Multiforme)
01/2022 - 04/2012
3
Brain Neoplasms (Brain Tumor)
01/2018 - 10/2013
3
Prostatic Neoplasms (Prostate Cancer)
01/2017 - 07/2015
2
Infections
01/2016 - 12/2014
2
Adenocarcinoma
09/2015 - 01/2004
2
Carcinogenesis
05/2013 - 08/2005
1
Colitis
01/2022
1
Disease Progression
01/2022
1
Necrosis
01/2022
1
Carcinoma (Carcinomatosis)
01/2019
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2019
1
Metaplasia
01/2019
1
Medulloblastoma
01/2016
1
Encephalitis (Encephalitis, Rasmussen)
09/2015
1
Breast Neoplasms (Breast Cancer)
12/2014
1
Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2013
1
Parathyroid Neoplasms (Parathyroid Neoplasm)
08/2008
1
Endometrial Hyperplasia
01/2004
1
Endometrial Neoplasms (Endometrial Cancer)
01/2004
Drug/Important Bio-Agent (IBA)
5
Chimeric Antigen Receptors
IBA
01/2022 - 09/2015
4
Antigens
IBA
01/2022 - 12/2009
4
Cytokines
IBA
01/2017 - 12/2009
3
Cytosine Deaminase
IBA
01/2021 - 05/2013
3
Flucytosine (Ancobon)
FDA Link
01/2021 - 05/2013
3
Fluorouracil (Carac)
FDA Link
Generic
01/2021 - 05/2013
3
Enzymes
IBA
01/2018 - 05/2013
3
Prodrugs
IBA
01/2018 - 05/2013
2
Hyaluronic Acid (Hyaluronan)
IBA
01/2019 - 09/2015
2
Dexamethasone (Maxidex)
FDA Link
Generic
01/2018 - 05/2013
2
Proteins (Proteins, Gene)
FDA Link
01/2016 - 01/2004
2
Interleukin-13
IBA
09/2015 - 04/2012
1
Steroids
IBA
01/2022
1
pembrolizumab
IBA
01/2022
1
Immune Checkpoint Inhibitors
IBA
01/2022
1
aldesleukin (Proleukin)
FDA Link
01/2022
1
Biomarkers (Surrogate Marker)
IBA
01/2018
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2018
1
Pharmaceutical Preparations
IBA
06/2017
1
compound 21
IBA
06/2017
1
Toll-Like Receptor 9
IBA
01/2017
1
STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)
IBA
01/2017
1
Oligonucleotides
IBA
01/2017
1
Tetracycline (Achromycin)
FDA Link
Generic
01/2017
1
Interleukin-13 Receptors (Interleukin 13 Receptor)
IBA
12/2016
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2016
1
Luciferases
IBA
01/2016
1
Tva receptor
IBA
01/2016
1
Arginase
IBA
01/2016
1
PEGPH20
IBA
09/2015
1
Serine Proteases (Serine Protease)
IBA
09/2015
1
Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)
IBA
09/2015
1
Granzymes (Granzyme)
IBA
08/2015
1
Small Interfering RNA (siRNA)
IBA
07/2015
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
07/2015
1
Androgens
IBA
07/2015
1
pertuzumab
IBA
12/2014
1
Trastuzumab (Herceptin)
FDA Link
12/2014
1
Ferrosoferric Oxide (Magnetite)
FDA Link
10/2013
1
Tyrosine Kinase Inhibitors
IBA
05/2013
1
bafetinib
IBA
05/2013
1
Imatinib Mesylate (Gleevec)
FDA Link
01/2013
1
Perforin
IBA
12/2009
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
12/2009
1
Dimenhydrinate (DMH)
FDA Link
Generic
08/2005
1
Cyclin-Dependent Kinases (cdk Proteins)
IBA
01/2004
1
Estrogens (Estrogen)
FDA Link
01/2004
1
Messenger RNA (mRNA)
IBA
01/2004
Therapy/Procedure
15
Therapeutics
01/2022 - 12/2009
5
Drug Therapy (Chemotherapy)
01/2021 - 12/2009
4
Immunotherapy
01/2022 - 08/2015
3
Radiotherapy
01/2022 - 12/2009
2
Transplantation
07/2015 - 10/2013
1
Catheters
01/2019
1
Intravenous Administration
01/2018
1
Intraventricular Infusions
01/2018
1
Castration
08/2015
1
Treatment Delay
12/2014
1
Intravenous Injections
10/2013
1
Radiofrequency Ablation
08/2008
1
Injections
08/2005